Despite numerous studies implicating OPN in a variety of cancers, therapeutic strategies targeting OPN function have not materialized (OPN is being evaluated as a biomarker for a number of human cancers including non-small cell lung cancer, head and neck cancer, and pancreatic cancer (www.clinicaltrials.gov)). Here, SPP1 is linked to familial pancreatic carcinoma.